Core Viewpoint - A class action lawsuit has been filed against Ardent Health, Inc. and its senior executives for securities fraud following a significant stock drop due to alleged violations of federal securities laws [1][3]. Company Overview - Ardent Health operates acute care hospitals and healthcare facilities, with a focus on the collection of accounts receivable [4]. Allegations of Fraud - The lawsuit claims that Ardent Health misrepresented its process for determining the collectability of accounts receivable, stating it relied on "detailed reviews of historical collections," while in reality, it used a "180-day cliff" method, leading to inflated accounts receivable figures [4]. Stock Performance Impact - On November 12, 2025, Ardent Health announced a $43 million revenue decrease for the quarter and a $54 million increase in professional liability reserves, resulting in a stock price drop of $4.75 per share, or over 33%, from $14.05 to $9.30 [5]. Legal Proceedings - Investors have until March 9, 2026, to request to lead the case in the U.S. District Court for the Middle District of Tennessee, under the caption Postiwala v. Ardent Health, Inc., et al. [3]. Legal Representation - Bleichmar Fonti & Auld LLP, a leading law firm in securities class actions, is representing the plaintiffs on a contingency fee basis, meaning no upfront costs for shareholders [6][7].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Ardent Health, Inc. securities between July 18, 2024, and November 12, 2025, of the March 9, 2026, deadline to become a lead plaintiff in a class action lawsuit [1]. Group 1: Class Action Details - Investors who purchased Ardent Health securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by submitting a form or contacting the law firm [3][6]. - The lead plaintiff must file a motion with the Court by March 9, 2026, to represent other class members in the litigation [3]. Group 2: Legal Representation - Investors are encouraged to select qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [4]. - Rosen Law Firm has a history of successful settlements, including the largest securities class action settlement against a Chinese company, and has recovered hundreds of millions for investors [4]. Group 3: Case Allegations - The lawsuit alleges that Ardent Health made misrepresentations regarding its accounts receivable, claiming to employ an active monitoring process that was not actually in place [5]. - Defendants reportedly downplayed issues related to increased claim denials by third-party payors and did not write off uncollectible accounts, leading to inflated accounts receivable figures [5]. - The firm also failed to maintain sufficient professional malpractice liability insurance, which was inadequate to cover claims arising from operations, particularly in the New Mexico market [5].

Core Viewpoint - A class action lawsuit has been filed against Ardent Health, Inc. and its senior executives for securities fraud following a significant stock drop due to alleged violations of federal securities laws [1][3]. Group 1: Lawsuit Details - The lawsuit is filed in the U.S. District Court for the Middle District of Tennessee, captioned Postiwala v. Ardent Health, Inc., et al., No. 3:26-cv-00022 [3]. - Investors have until March 9, 2026, to request to be appointed to lead the case [3]. - The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Ardent Health securities [3]. Group 2: Allegations Against Ardent Health - Ardent Health operates acute care hospitals and healthcare facilities, with a critical focus on the collection of accounts receivable [4]. - The lawsuit alleges that Ardent Health misrepresented its process for determining the collectability of accounts receivable, claiming reliance on "detailed reviews of historical collections," while actually using a "180-day cliff" method [4]. - This misrepresentation allowed Ardent Health to report inflated accounts receivable and delay recognizing losses on uncollectable accounts, constituting a violation of federal securities laws [4]. Group 3: Stock Price Impact - On November 12, 2025, Ardent Health disclosed a $43 million revenue decrease for the quarter due to "hindsight evaluations of historical collection trends" and increased its professional liability reserves by $54 million [5]. - Following this announcement, Ardent Health's stock price fell by $4.75 per share, a decline of over 33%, from $14.05 to $9.30 per share [5].

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Ardent To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Ardent between July 18, 2024 and November 12, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Jan. 24, 2026 (GLOBE NEWSWIRE) -- Faruqi & ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Ardent Health, Inc. securities between July 18, 2024, and November 12, 2025, of the March 9, 2026, deadline to become a lead plaintiff in a class action lawsuit [1]. Group 1: Class Action Details - Investors who purchased Ardent Health securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [3][6]. - The deadline to move the Court to serve as lead plaintiff is March 9, 2026, with the lead plaintiff acting on behalf of other class members [3]. Group 2: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting their own experience and success in this area [4]. - The firm has achieved significant settlements in the past, including the largest securities class action settlement against a Chinese company and has consistently ranked highly in securities class action settlements [4]. Group 3: Case Background - The lawsuit alleges that Ardent Health made misrepresentations regarding its accounts receivable, claiming an active monitoring process that was not actually in place [5]. - Defendants reportedly downplayed issues related to increased claim denials by third-party payors and did not write off uncollectible accounts, leading to inflated accounts receivable figures [5]. - The firm also claims that Ardent Health's professional malpractice liability insurance was insufficient to cover claims, contrary to public representations [5].

Core View - Class action lawsuits have been filed on behalf of shareholders of several publicly-traded companies, with deadlines for filing lead plaintiff motions approaching [1] Varonis Systems, Inc. (NASDAQ: VRNS) - Class period is from February 4, 2025, to October 28, 2025, with a lead plaintiff deadline of March 9, 2026 [2] - Allegations include that Varonis was not equipped to sustain its Annual Recurring Revenue (ARR) growth without high quarterly conversions, making positive statements about its business misleading [2] Ardent Health, Inc. (NYSE: ARDT) - Class period is from July 18, 2024, to November 12, 2025, with a lead plaintiff deadline of March 9, 2026 [3] - Allegations state that Ardent misrepresented its accounts receivable framework and did not maintain sufficient malpractice liability insurance, leading to misleading positive statements about its operations [3] CoreWeave, Inc. (NASDAQ: CRWV) - Class period is from March 28, 2025, to December 15, 2025, with a lead plaintiff deadline of March 13, 2026 [4] - Allegations include overstating the company's ability to meet customer demand and underestimating risks associated with reliance on a single third-party data center supplier, resulting in misleading statements about its business [4] Bath & Body Works, Inc. (NYSE: BBWI) - Class period is from June 4, 2024, to November 19, 2025, with a lead plaintiff deadline of March 16, 2026 [5] - Allegations indicate that the company's strategy for growth was ineffective, leading to reliance on brand collaborations to mask weak financial results, which were misleadingly presented [5]

New York, New York--(Newsfile Corp. - January 23, 2026) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that it has filed a class action lawsuit against Ardent Health, Inc. (NYSE: ARDT) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from potential violations of the federal securities laws. If you invested in Ardent Health, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/ardent-heal ...

NEW YORK, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Ardent Health, Inc. ("Ardent Health, Inc." or the "Company") (NYSE: ARDT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Ardent Health, Inc. investors who were adversely affected by alleged securities fraud between July 18, 2024 and November 12, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/ar ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Ardent Health, Inc. securities between July 18, 2024, and November 12, 2025, of the March 9, 2026, deadline to become a lead plaintiff in a class action lawsuit [1] Group 1: Class Action Details - Investors who purchased Ardent Health securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and interested parties must move the Court by March 9, 2026, to serve as lead plaintiff [2] Group 2: Rosen Law Firm's Credentials - Rosen Law Firm specializes in securities class actions and has a strong track record, including the largest securities class action settlement against a Chinese company [3] - The firm has been ranked No. 1 for securities class action settlements in 2017 and has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 [3] Group 3: Case Allegations - The lawsuit alleges that Ardent Health made misrepresentations regarding its accounts receivable, claiming an active monitoring process that was not actually employed [4] - Defendants downplayed issues related to increased claim denials by third-party payors and did not write off uncollectible accounts, leading to inflated accounts receivable figures [4] - Ardent Health's professional liability reserves were insufficient to cover claims, contrary to their public statements about maintaining adequate insurance [4]

BENSALEM, Pa., Jan. 22, 2026 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Ardent Health, Inc. ("Ardent" or the "Company") (NYSE: ARDT). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ARDENT HEALTH, INC. (ARDT), CONTACT THE LAW OFFICES OF HOWARD G. SMITH BEFORE MARCH 9, 2026 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT. Contact the Law Offices o ...